BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ben-Dov IZ, Oster Y, Tzukert K, Alster T, Bader R, Israeli R, Asayag H, Aharon M, Burstein I, Pri-Chen H, Imam A, Abel R, Mor-Yosef Levi I, Khalaileh A, Oiknine-Djian E, Bloch A, Wolf DG, Dranitzki Elhalel M. Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up. J Nephrol 2022. [PMID: 34988942 DOI: 10.1007/s40620-021-01210-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Malik SA, Modarage K, Goggolidou P. A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals. F1000Res 2022;11:909. [DOI: 10.12688/f1000research.122820.1] [Reference Citation Analysis]
2 Ohki Y, Kawabe M, Yamamoto I, Katsumata H, Nakada Y, Kobayashi A, Urabe F, Miki J, Yamada H, Kimura T, Matsuo N, Tanno Y, Horino T, Ohkido I, Yamamoto H, Yokoo T. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients. Front Microbiol 2022;13:922042. [PMID: 35756063 DOI: 10.3389/fmicb.2022.922042] [Reference Citation Analysis]